PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support.
Marcelo B BastosMaarten P van WiechenNicolas M Van MieghemPublished in: Future cardiology (2020)
Contemporary state of the art percutaneous coronary intervention techniques offer treatment strategies and solutions to an increasing number of patients with heart failure and complex coronary artery disease. Percutaneous mechanical circulatory support is intended to alleviate the mechanical and energetic workload imposed to a failing ventricle by reducing left ventricle pressures and volumes and potentially also increasing coronary blood flow. The PulseCath iVAC2L is a transaortic left ventricular assist device that applies a pneumatic driving system to produce pulsatile forward flow. Herein, the essential aspects regarding iVAC2L are discussed with focus on its mechanisms of action and the available clinical experience.
Keyphrases
- coronary artery disease
- blood flow
- percutaneous coronary intervention
- left ventricular assist device
- pulmonary artery
- coronary artery bypass grafting
- pulmonary hypertension
- st segment elevation myocardial infarction
- cardiovascular events
- coronary artery
- acute myocardial infarction
- extracorporeal membrane oxygenation
- mitral valve
- acute coronary syndrome
- antiplatelet therapy
- st elevation myocardial infarction
- minimally invasive
- congenital heart disease
- ultrasound guided